US CDC delays report highlighting COVID-19 vaccine benefits
The acting director of the U.S. Centers for Disease Control and Prevention (CDC) has postponed the release of a report demonstrating that COVID-19 vaccines reduced emergency department visits and hospitalizations for healthy adults during the previous winter by approximately 50%, according to the Washington Post.
The study, which has not been independently verified, reportedly included data from vaccines produced by Moderna Inc, Pfizer Inc, and Novavax Inc. Health officials have not yet provided a public explanation for the delay, and the U.S. Department of Health and Human Services did not immediately comment.
The postponement has raised questions among scientists and public health experts, who emphasize the importance of timely data on vaccine effectiveness to guide policy decisions and public guidance during ongoing COVID-19 vaccination campaigns.
-
16:06
-
16:00
-
15:45
-
15:30
-
15:15
-
15:00
-
14:45
-
14:30
-
14:15
-
13:50
-
13:35
-
13:20
-
13:05
-
12:50
-
12:35
-
12:20
-
12:05
-
11:50
-
11:35
-
11:20
-
11:05
-
10:50
-
10:35
-
10:20
-
10:19
-
10:18
-
10:05
-
09:50
-
09:41
-
09:26
-
09:19
-
09:18
-
09:07
-
09:01
-
08:37
-
08:33
-
08:25
-
08:24
-
08:23
-
08:22
-
08:19
-
08:18
-
08:17
-
22:15
-
22:00
-
21:45
-
21:30
-
21:15
-
21:00
-
20:45
-
20:30
-
20:15
-
20:00
-
19:45
-
19:30
-
19:15
-
19:00
-
18:45
-
18:30
-
18:15
-
18:00
-
17:45
-
17:34
-
17:30
-
17:15
-
17:00
-
16:45
-
16:30
-
16:26
-
16:15
-
16:15